secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001398733-26-000007
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics files February 2026 investor presentation without new financial data
--------------------------------------------------------------------------------

- Presentation furnished under Regulation FD; intended for meetings with institutional investors.
- Only a title slide was provided in the exhibit; no specific financial figures or guidance.
- No updates to product pipeline, revenue, or strategic initiatives were disclosed.
- Ticker AQST continues to trade on Nasdaq; corporate address unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/0001398733-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/aqst-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001398733-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer